Arash Davani

593 total citations
9 papers, 219 citations indexed

About

Arash Davani is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Arash Davani has authored 9 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Arash Davani's work include Cardiac Fibrosis and Remodeling (3 papers), Diabetes and associated disorders (2 papers) and Diabetes Management and Research (2 papers). Arash Davani is often cited by papers focused on Cardiac Fibrosis and Remodeling (3 papers), Diabetes and associated disorders (2 papers) and Diabetes Management and Research (2 papers). Arash Davani collaborates with scholars based in United States, Slovakia and Czechia. Arash Davani's co-authors include Magdy Girgis, Anweshan Samanta, Buddhadeb Dawn, Robert J. Vincent, Guangming Cheng, Harold K. Elias, Sheng Ye, Runming Jin, Ou‐Li Wang and Lei Chen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Arash Davani

8 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arash Davani United States	3	144	90	31	24	23	9	219
Toby P. Thomas United States	7	120 0.8×	107 1.2×	39 1.3×	19 0.8×	21 0.9×	7	217
Sherin Saheera United States	9	109 0.8×	156 1.7×	43 1.4×	37 1.5×	14 0.6×	16	300
Xuexin Jin China	7	137 1.0×	118 1.3×	31 1.0×	25 1.0×	15 0.7×	13	248
Simina‐Ramona Selejan Germany	8	96 0.7×	50 0.6×	24 0.8×	18 0.8×	15 0.7×	11	179
Huanji Zhang China	8	91 0.6×	158 1.8×	40 1.3×	21 0.9×	18 0.8×	17	337
Genlong Xue China	9	181 1.3×	146 1.6×	42 1.4×	39 1.6×	22 1.0×	14	319
Lingfang Zhuang China	8	97 0.7×	151 1.7×	24 0.8×	43 1.8×	12 0.5×	16	266
Jiuchun Qiu China	9	155 1.1×	145 1.6×	34 1.1×	22 0.9×	26 1.1×	18	320
Bochra Tourki United States	10	101 0.7×	132 1.5×	32 1.0×	62 2.6×	26 1.1×	15	296
Osamu Kume Japan	9	274 1.9×	87 1.0×	19 0.6×	23 1.0×	28 1.2×	12	382

Countries citing papers authored by Arash Davani

Since Specialization

Citations

This map shows the geographic impact of Arash Davani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Davani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Davani more than expected).

Fields of papers citing papers by Arash Davani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Davani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Davani. The network helps show where Arash Davani may publish in the future.

Co-authorship network of co-authors of Arash Davani

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Davani. A scholar is included among the top collaborators of Arash Davani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Davani. Arash Davani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sláma, Petr, et al.. (2024). Clinical Evaluation of AMNIODERM+® Wound Dressing Containing Non-Viable Human Amniotic Membrane: Retrospective-Perspective Clinical Trial. BioTech. 13(3). 36–36. 1 indexed citations

Davani, Arash, et al.. (2023). Prevalence of Positivity for Diabetes-Associated Autoantibodies in Individuals with Type 2 Diabetes and Their Further Characterisation: Cross-sectional Study from Slovakia. Diabetes Therapy. 14(9). 1537–1548. 4 indexed citations

Martinka, Emil, et al.. (2017). [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].. PubMed. 62(7-8). 521–33. 1 indexed citations

Zhao, Lin, Guangming Cheng, Runming Jin, et al.. (2016). Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction. Circulation Research. 118(12). 1918–1929. 202 indexed citations

Zhao, Lin, Guangming Cheng, Runming Jin, et al.. (2015). CAMKII IS CRITICAL FOR THE UPREGULATION OF STAT3 SIGNALING IN PATHOGENESIS OF CARDIOMYOCYTE HYPERTROPHY. Journal of the American College of Cardiology. 65(10). A903–A903. 1 indexed citations

Cheng, Guangming, Dominika Berdecka, Yu‐Ting Xuan, et al.. (2015). Abstract 16673: Intramyocardial Injection of MSC-derived Extracellular Vesicles Confers Superior Cardiac Repair After a Reperfused Myocardial Infarction. Circulation. 132(suppl_3). 1 indexed citations

Samanta, Anweshan, Guangming Cheng, Arash Davani, et al.. (2014). Abstract 15693: Genetic Deletion of Interleukin-6 Attenuates Left Ventricular Dysfunction and Remodeling After a Reperfused Myocardial Infarction. Circulation. 130. 1 indexed citations

Cheng, Guangming, Lin Zhao, Lei Chen, et al.. (2014). Abstract 15923: CaMKII Links ER Stress Signaling in Pressure Overload-Induced Left Ventricular Hypertrophy and Failure. Circulation. 130(suppl_2). 1 indexed citations

Sanaat, Zohreh, et al.. (2014). Does Chemotherapy Change Expression of VEGF A&C and MVD in Acute Myeloid Leukemia?. PubMed. 8(3). 24–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact